The effect of two concentrations of delta-9 tetrahydrocannabinol (THC, the active ingredient in Cannabis) on saliva-based drug detection systems and driving performance

Phase 1

Completed

• Conditions: Drugged drivers; Other - Research that is not of generic health relevance and not applicable to specific health categories listed above

• Registration Number: ACTRN12616000267459
• Lead Sponsor: Swinburne University of Techology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-02-29
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Aged between 21 and 55 years

2. Hold a full drivers licence (no ‘P’ plates)

3. Participants will also be required to have experimented with cannaboids previously (self-disclosure).

4 Have no history of past substance abuse or current abuse of illicit drugs

5. Have no pre-existing physical or neurological conditions, no previous or current history of severe psychiatric, cardiac, endocrine, gastrointestinal, or bleeding disorders

6. Not currently pregnant or lactating

Exclusion Criteria

1. Inability to speak or read English

2. History of drug or substance abuse or current illicit drug abuse

3. History of neurological conditions or previous or current history of psychiatric, cardiac, endocrine, gastrointestinal, or bleeding disorders

4 Taking any form of medication within 5 days of admission (except for prophylactic antibiotics, or other routine medications to treat benign conditions, such as antibiotics to treat acne) and agree not to take any medication throughout the study

5. Current participation in any other trials involving investigational or marketed products within 30 days prior to the screening visit

6. Unable to participate in all scheduled visits, treatment plan, tests and other trial procedures according to the protocol

7. Unable to provide a personally signed and dated informed consent indicating that the subject has been informed of all pertinent aspects of the trial.

Study & Design

• Study Type: Interventional
• Study Design: Not specified